Topics
Glioblastoma | Treatment | Targeted therapy | Tepotinib
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Tepotinib
Pham LC, Weller L, Gann CN, Schumacher KM, Vlassak S, Swanson T,
Highsmith K, O'Brien BJ, Nash S, Aaroe A, de Groot JF, Majd NK.
Prolonged complete response to
adjuvant tepotinib in a patient with newly diagnosed disseminated
glioblastoma harboring mesenchymal-epithelial transition
fusion.
Oncologist.
2024 May 30:oyae100. doi:
10.1093/oncolo/oyae100. PMID:
38815166. Case report. ˍ